Sinopharm Tech Sets 24 September 2026 Board Meeting to Review FY 2026 Results and Dividend Matters

Bulletin Express

Sep 11

Sinopharm Tech Holdings Limited has scheduled a board meeting for Thursday, 24 September 2026. According to the company’s announcement to the Hong Kong Stock Exchange, directors will review and approve the audited annual results for the financial year ended 30 June 2026.

In addition to the results approval, the board will consider two capital-allocation items:

1. A proposal to defer payment of the annual preferred distribution on the company’s outstanding convertible preference shares. 2. A decision on whether to declare a final dividend on the ordinary shares.

The announcement was authorised by Executive Director Ms. Kwok Shuk Yi on behalf of the board, which currently consists of two executive directors and four independent non-executive directors.

The company stated that the notice will remain available on HKEX’s “Latest Listed Company Information” page and on Sinopharm Tech’s corporate website for at least seven days from its publication date of 11 September 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1103029534"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1103029534\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1103029534?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-11 19:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103029534","market":"us","top_or_hot":-1,"title":"Sinopharm Tech Sets 24 September 2026 Board Meeting to Review FY 2026 Results and Dividend Matters","media":"Bulletin Express","content":"<p>Sinopharm Tech Holdings Limited has scheduled a board meeting for Thursday, 24 September 2026. According to the company’s announcement to the Hong Kong Stock Exchange, directors will review and approve the audited annual results for the financial year ended 30 June 2026.</p>\n<p>In addition to the results approval, the board will consider two capital-allocation items:</p>\n<p>1. A proposal to defer payment of the annual preferred distribution on the company’s outstanding convertible preference shares.  \n2. A decision on whether to declare a final dividend on the ordinary shares.</p>\n<p>The announcement was authorised by Executive Director Ms. Kwok Shuk Yi on behalf of the board, which currently consists of two executive directors and four independent non-executive directors.</p>\n<p>The company stated that the notice will remain available on HKEX’s “Latest Listed Company Information” page and on Sinopharm Tech’s corporate website for at least seven days from its publication date of 11 September 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinopharm Tech Sets 24 September 2026 Board Meeting to Review FY 2026 Results and Dividend Matters</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinopharm Tech Sets 24 September 2026 Board Meeting to Review FY 2026 Results and Dividend Matters\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-11 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinopharm Tech Holdings Limited has scheduled a board meeting for Thursday, 24 September 2026. According to the company’s announcement to the Hong Kong Stock Exchange, directors will review and approve the audited annual results for the financial year ended 30 June 2026.</p>\n<p>In addition to the results approval, the board will consider two capital-allocation items:</p>\n<p>1. A proposal to defer payment of the annual preferred distribution on the company’s outstanding convertible preference shares.  \n2. A decision on whether to declare a final dividend on the ordinary shares.</p>\n<p>The announcement was authorised by Executive Director Ms. Kwok Shuk Yi on behalf of the board, which currently consists of two executive directors and four independent non-executive directors.</p>\n<p>The company stated that the notice will remain available on HKEX’s “Latest Listed Company Information” page and on Sinopharm Tech’s corporate website for at least seven days from its publication date of 11 September 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08156","symbol_name":"国药科技股份","start_time":0,"source_url":"","article_id":"1103029534","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103029534","pubTimestamp":1789127033,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinopharm Tech Holdings Limited has scheduled a board meeting for Thursday, 24 September 2026. According to the company’s announcement to the Hong Kong Stock Exchange, directors will review and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08156":"国药科技股份"},"translate_title":"国药科技定于2026年9月24日召开董事会会议，审查2026财年业绩和股息事宜","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08156":1},"content_text":"Sinopharm Tech Holdings Limited has scheduled a board meeting for Thursday, 24 September 2026. According to the company’s announcement to the Hong Kong Stock Exchange, directors will review and approve the audited annual results for the financial year ended 30 June 2026.\nIn addition to the results approval, the board will consider two capital-allocation items:\n1. A proposal to defer payment of the annual preferred distribution on the company’s outstanding convertible preference shares.  \n2. A decision on whether to declare a final dividend on the ordinary shares.\nThe announcement was authorised by Executive Director Ms. Kwok Shuk Yi on behalf of the board, which currently consists of two executive directors and four independent non-executive directors.\nThe company stated that the notice will remain available on HKEX’s “Latest Listed Company Information” page and on Sinopharm Tech’s corporate website for at least seven days from its publication date of 11 September 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}